5th Partnering with ACO Summit -

5th Partnering with ACO Summit
June 1 - 2, 2015
Philadelphia, PA

Engaging with ACOs through cross industry platforms

5th Partnering with ACO Summit – 5th Partnering with ACO Summit

In the rapidly changing US healthcare system, interest in Accountable Care Organizations (ACOs) as a model to deliver high-quality and cost-effective care has grown significantly in the recent years. For life science companies, this presents new challenges as well as opportunities. These companies are being pushed to rework their current approach from dealing with individual consumers to now working with coordinated care networks. Even though these new networks propose many challenges for the life science industry, it also presents the opportunity to improve the quality of patient care, reduce treatment costs and build cross industry partnerships that are financially beneficial to all stakeholders.

The 5th Partnering with ACOs Summit is the first and leading event to discuss strategies for life science companies to effectively collaborate with ACOs. Our expert faculty includes life science professionals, ACO executives and insurance providers who will provide real-life examples and insight on how your organization can improve patient outcomes and reduce treatment costs while building valuable strategic cross-industry relationships with ACOs.

This year’s program features leading industry experts from organizations such as Astellas, Bayer Healthcare, Glaxosmithkline, Merck and Pfizer, just to name a few! Additionally, this event will be hosted at Thomas Jefferson University in Philadelphia, PA, and will be chaired by Dr. David Nash, Dean of the Jefferson School of Population Health. This partnership will enhance our dynamic conference agenda, which includes innovative session topics such as demonstrating the value of your products to ACOs, health economics and outcomes, risk sharing, value-based contracting, and much more!

Top Five Reasons to Attend

  1. Develop strategies to effectively communicate a value proposition to potential ACO partners
  2. Understand the importance of the Prescription Drug Program in an Accountable Care Organization’s partnership with industry
  3. Hear best practices in implementing risk sharing in cross industry partnerships
  4. Identify the impact of the CMS Bundled Payment Initiative on ACO collaborations with industry
  5. Implement performance metrics in cross industry relationships to determine operational effectiveness

Who Should Attend

This conference is designed for professionals from pharmaceutical, biotech and medical device companies, as well as those from laboratories and ACOs. Life science industry professionals with responsibilities in the following areas should attend:

  • Pricing and Reimbursement
  • Health Economics Outcomes Research
  • Account Management
  • Brand/Product Management
  • Organized/Managed Markets
  • Market Access
  • Contracting
  • Medical Affairs, Medical Science Liaison & Scientific Account Liaisons
  • Sales and Marketing
  • Policy and Government Affairs
  • Managed/Coordinated Care
  • Health Science/Health Policy

This event is also of interest for professionals from ACOs, health plans, physician organizations and insurance companies with the following responsibilities:

  • Executive Leadership
  • Decision Support
  • Physician Services
  • Quality and Care Management
  • Partnership Administration
  • Managed Care
  • Delivery System Reform
  • Internal Communications
  • Strategy and Marketing
  • Legal Affairs
live chat software